Abbott MediaRoom - Press Releases

Month Year

Apr 26, 2022
- Photos 1
Abbott Recommends Rejection of Below-Market Mini-Tender Offer by TRC Capital Investment Corporation
Apr 25, 2022
- Photos 1
Abbott Strengthens Its Connected Care Technologies with Latest NeuroSphere™ myPath™ Digital Health App
Apr 20, 2022
- Photos 1
Abbott Reports First-Quarter 2022 Results
Apr 4, 2022
- Photos 1
Abbott Receives FDA Approval for Aveir™ VR Leadless Pacemaker System to Treat Patients with Slow Heart Rhythms
Mar 30, 2022
- Photos 1
Abbott and LISC Team Up to Address Diversity and Equity Gaps in the Healthcare Industry Supply Chain
Mar 28, 2022
- Photos 1
Abbott Hosts Conference Call for First-Quarter Earnings
Mar 24, 2022
- Photos 1
Abbott's FreeStyle® Libre is First and Only CGM System to Gain Expanded Reimbursement in Japan to Include All People with Diabetes Who Use Insulin
Mar 1, 2022

Military Members, Families and Retirees Get Simplified Access to Abbott’s FreeStyle® Libre 2 system Through TRICARE®

- TRICARE members now have faster, easier, and more convenient access to continuous glucose monitoring
- Abbott’s FreeStyle Libre 2 system will now be on the brand-name formulary and available through retail pharmacies, home delivery and military treatment facilities
Feb 21, 2022

Abbott's CardioMEMS™ HF System Receives FDA Approval to Support Patients Battling Earlier-Stage Heart Failure

- New expanded indication provides patients suffering from earlier stages of heart failure access to the CardioMEMS™ HF System, a small implantable sensor that can flag early warning signs of worsening heart failure
- FDA approval was supported by data from the GUIDE-HF trial, which suggested that the CardioMEMS sensor can reduce hospitalizations and improve care for more types of patients living with heart failure
Feb 18, 2022
- Photos 1
Abbott Declares 393rd Consecutive Quarterly Dividend

Show per page

true

accessibility

You are about to exit for another Abbott country or region specific website

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

The website you have requested also may not be optimized for your specific screen size.

Do you wish to continue and exit this website?

yes no

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.

The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?

yes no

accessibility

Asset Warning

yes no

PRESS RELEASES

You are about to exit for another Abbott country or region specific website

Do you wish to continue and exit this website?

You are about to exit the Abbott family of websites for a 3rd party website

Do you wish to continue and exit this website?